Neuphoria Therapeutics Inc. (NEUP)
NEUP trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$3.39
+2.11% on the day
Market cap
$18.3M
Nano cap
Revenue · 2025
$15.6M
No prior year to compare
Net income · 2025
-$370K
-2.4% net margin
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC XBRL frames, calendar 2025.
Profile
| Field | Value |
|---|---|
| Ticker | NEUP on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | United States |
| IPO year | 2021 |
| SEC CIK | 0001191070 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | C3 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $15.6M |
| Net income | -$370K |
| Operating income | -$1.1M |
| Net margin | -2.4% |
| Operating margin | -7.2% |
| Revenue growth | No prior-year revenue to compare |
| Cash | $22.2M |
| Total assets | $36.6M |
| P/E (computed) | Net income was not positive |
| P/S (computed) | 1.2× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document PROSPECTUS SUPPLEMENT | 424B5 | 2025-11-14 |
| Latest annual report | 10-K | 2026-09-18 |
| Latest quarterly / interim | 10-Q | 2026-05-15 |
| Latest current report CURRENT REPORT | 8-K | 2026-07-24 |
| Latest proxy | DEFA14A | 2026-09-18 |
Source: SEC EDGAR submissions feed, 418 recent filings. All filings on EDGAR.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| AKTX | Akari Therapeutics plc ADS | $7.90 | -7.49% | $18.1M |
| RADX | Radiopharm Theranostics Limited | $1.20 | +8.10% | $17.3M |
| QNRX | Quoin Pharmaceuticals Ltd. | $4.15 | -4.82% | $19.9M |
| OPTH | Optimi Health Corp. Common Shares | $3.50 | -3.58% | $20.0M |
| NCEL | NewcelX Ltd. | $2.84 | -2.20% | $16.4M |
| COCP | Cocrystal Pharma Inc. | $1.08 | +1.89% | $20.8M |
| UPC | Universe Pharmaceuticals Inc. | $4.27 | +3.39% | $21.5M |
| AYTU | Aytu BioPharma Inc. | $1.99 | +1.01% | $21.6M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier